These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6683615)

  • 1. Evaluation of a thromboxane synthetase inhibitor in circumflex coronary artery occlusion and reperfusion.
    Huddleston CB; Lupinetti FM; Clanton J; Collins J; Oates JA; Hammon JW
    Curr Surg; 1983; 40(3):211-5. PubMed ID: 6683615
    [No Abstract]   [Full Text] [Related]  

  • 2. The effects of RO-22-4679, a thromboxane synthetase inhibitor, on ventricular fibrillation induced by coronary artery occlusion in conscious dogs.
    Huddleston CB; Lupinetti FM; Laws KH; Collins JC; Clanton JA; Hawiger JJ; Oates JA; Hammon JW
    Circ Res; 1983 May; 52(5):608-13. PubMed ID: 6682723
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of the selective thromboxane synthetase inhibitor, dazoxiben, on cyclic flow variations in stenosed canine coronary arteries.
    Bush LR; Campbell WB; Tilton GD; Buja LM; Willerson JT
    Trans Assoc Am Physicians; 1983; 96():103-12. PubMed ID: 6687298
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of the thromboxane synthetase inhibitor UK-37,248 (dazoxiben) upon platelet aggregation, coronary artery thrombosis and vascular reactivity.
    Schumacher WA; Lucchesi BR
    J Pharmacol Exp Ther; 1983 Dec; 227(3):790-6. PubMed ID: 6418881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amelioration of the deleterious effects of platelets activated during cardiopulmonary bypass. Comparison of a thromboxane synthetase inhibitor and a prostacyclin analogue.
    Huddleston CB; Hammon JW; Wareing TH; Lupinetti FM; Clanton JA; Collins JC; Bender HW
    J Thorac Cardiovasc Surg; 1985 Feb; 89(2):190-5. PubMed ID: 2578591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the thromboxane synthetase inhibitor dazoxiben and the prostacyclin mimetic iloprost in an animal model of acute ischaemia and reperfusion.
    Thiemermann C; Schrör K
    Biomed Biochim Acta; 1984; 43(8-9):S151-4. PubMed ID: 6083783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of a thromboxane synthetase inhibitor, Y-20811, on infarct size, neutrophil accumulation, and arrhythmias after coronary artery occlusion and reperfusion in dogs.
    Sato N; Endo T; Kiuchi K; Hayakawa H
    J Cardiovasc Pharmacol; 1993 Mar; 21(3):353-61. PubMed ID: 7681494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical prospects for a thromboxane synthetase inhibitor. A Pfizer Central Research Symposium--26th-27th March, 1982.
    Br J Clin Pharmacol; 1983; 15 Suppl 1():5S-139S. PubMed ID: 6681704
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of dazoxiben on arrhythmias and ventricular fibrillation induced by coronary artery occlusion and reperfusion in anaesthetised greyhounds.
    Coker SJ; Parratt JR
    Br J Clin Pharmacol; 1983; 15 Suppl 1(Suppl 1):87S-95S. PubMed ID: 6681710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationships between the severity of myocardial ischaemia, reperfusion-induced ventricular fibrillation, and the late administration of dazmegrel or nifedipine.
    Coker SJ; Parratt JR
    J Cardiovasc Pharmacol; 1985; 7(2):327-34. PubMed ID: 2581088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comments on "The effects of RO-22-4679, a thromboxane synthetase inhibitor, on ventricular fibrillation induced by coronary artery occlusion in conscious dogs".
    Crampton RS; Kaiser DL
    Circ Res; 1984 Apr; 54(4):474-5. PubMed ID: 6538818
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of thromboxane synthetase inhibition on vulnerability to ventricular arrhythmia following coronary occlusion.
    O'Connor KM; Friehling TD; Kelliher GJ; MacNab MW; Wetstein L; Kowey PR
    Am Heart J; 1986 Apr; 111(4):683-8. PubMed ID: 3953390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved lactate extraction in dogs with coronary artery ligation following administration of a thromboxane synthetase inhibitor.
    Eddy LJ; Oei HH; Glenn TM
    Res Commun Chem Pathol Pharmacol; 1983 Jan; 39(1):87-97. PubMed ID: 6682567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thromboxane synthetase inhibition with CGS 13080 improves coronary blood flow after streptokinase-induced thrombolysis.
    Mickelson JK; Simpson PJ; Gallas MT; Lucchesi BR
    Am Heart J; 1987 Jun; 113(6):1345-52. PubMed ID: 3591602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endogenous prostacyclin contributes to the efficacy of a thromboxane synthetase inhibitor for preventing coronary artery thrombosis.
    Aiken JW; Shebuski RJ; Miller OV; Gorman RR
    J Pharmacol Exp Ther; 1981 Nov; 219(2):299-308. PubMed ID: 6270303
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of OKY-1581, a thromboxane synthetase inhibitor, on coronary thrombosis in the conscious dog.
    Shea MJ; Driscoll EM; Romson JL; Pitt B; Lucchesi BR
    Eur J Pharmacol; 1984 Oct; 105(3-4):285-91. PubMed ID: 6542526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of a thromboxane A2 synthetase inhibitor on ventricular fibrillation threshold during coronary artery occlusion and reperfusion.
    Toda I; Nozaki A; Kawakubo K; Murakawa Y; Inoue H; Yoshimoto N; Sugimoto T
    Jpn Heart J; 1990 Jan; 31(1):87-97. PubMed ID: 2335849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of beta-adrenoceptor blockade and of thromboxane synthetase inhibition, alone and in combination, on arrhythmias resulting from myocardial ischemia.
    Wainwright CL; Parratt JR
    Adv Myocardiol; 1985; 6():573-84. PubMed ID: 4039460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of platelets with the vessel wall in the pathophysiology of sudden cardiac death.
    Hammon JW; Oates JA
    Circulation; 1986 Feb; 73(2):224-6. PubMed ID: 3510761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of PGI2 analog iloprost on myocardial infarct size, regional myocardial blood flow, and platelet function in rabbits with coronary artery occlusion followed by reperfusion.
    Golino P; Cappelli-Bigazzi M; Perrone-Filardi P; Nevola E; Quattrin S; Salvatore M; Chiariello M
    Adv Prostaglandin Thromboxane Leukot Res; 1987; 17A():377-80. PubMed ID: 2444078
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.